Societal Color Logo and Tagline.png
Societal CDMO Reports First Quarter 2022 Financial Results
May 11, 2022 16:05 ET | Societal CDMO, Inc.
Recorded Q1 Revenue of $21 Million; A 26% Increase Compared to Prior Year Period Signed Multiple New Business Agreements Spanning Early Stage Through Commercial Manufacturing Launching Aseptic...
Societal Color Logo and Tagline.png
Societal CDMO Signs Three-Year Manufacturing and Supply Agreement With InfectoPharm for Ritalin LA® in Europe
May 05, 2022 07:00 ET | Societal CDMO, Inc.
SAN DIEGO, and GAINESVILLE, Ga., May 05, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO)...
Societal Color Logo and Tagline.png
Societal CDMO to Report Financial Results for First Quarter 2022 on May 11, 2022
May 04, 2022 16:05 ET | Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., May 04, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO)...
Societal Color Logo and Tagline.png
Societal CDMO Secures Manufacturing and Packaging Task Order Award from National Cancer Institute (NCI)
April 27, 2022 07:00 ET | Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., April 27, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to...
Societal Color Logo and Tagline.png
Societal CDMO Reports Inducement Grants for New Staff
April 06, 2022 16:05 ET | Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., April 06, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to...
Societal Color Logo and Tagline
Recro Announces Name Change to Societal CDMO to Reflect Corporate Expansion and Transformation
March 21, 2022 07:00 ET | Recro Pharma, Inc.
With Expanded Industry Expertise, Enhanced Service Offerings and Bi-Coastal Operations, Company Now Optimally Positioned to Support Customers’ Goal of Delivering Impactful Medicines to SocietyNew...
LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro Reports Fourth Quarter and Year End 2021 Financial Results
March 01, 2022 16:05 ET | Recro Pharma, Inc.
Recorded Q4 Revenue of $22.3 Million; Full Year Revenue of $75.4 Million More than Tripled Customer Base in 2021; Significantly Diversified Clientele Grew Organic New Business by 63% in 2021; Grew...
LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro Reports Progress Towards Launching Fill/Finish and Lyophilization Capabilities at San Diego Facility
February 23, 2022 07:00 ET | Recro Pharma, Inc.
SAN DIEGO, Calif. and GAINESVILLE, Ga., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to...
LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro to Report Financial Results for Fourth Quarter and Year-end 2021 on March 1, 2022
February 22, 2022 16:05 ET | Recro Pharma, Inc.
SAN DIEGO and GAINESVILLE, Ga., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving...
LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro Appoints Eduardo Uribe as Head of Quality for Recro San Diego
January 19, 2022 07:00 ET | Recro Pharma, Inc.
SAN DIEGO and GAINESVILLE, Ga., Jan. 19, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex...